Atrophic Vaginitis Clinical Trial
Objective：To evaluate the effect and safety of the traditional chinese medicine oil agent on
senile atrophic compared as compared to estriol cream in aged woman.
Design: A randomized double-blind controlled trial.
Setting: The hospital ward.
Participants: 200 postmenopausal woman with senile vaginitis (mean age 56).
Intervention: The traditional chinese medicine oil and estriol cream were separately
intravaginal administrated in treatment group and control group for 3 weeks，follow-up 1
month.
Measurement: symptom improving(pain and itch) and onset time, edema-size of vaginal wall,
vaginal discharge, and PH changes.
80 postmenopausal women living in the communities near the hospital with AV (atrophic vaginitis) symptoms were recruited for this clinical trial. Patients with AV receiving external treatment and requiring hospitalization were randomized in a double-blind, single-centre trial. Subjects received CHCO (Chinese Herbal Compound Ointment) topical vaginal application in experimental group, while estriol in control group. The dosage of medicine for single treatment once a day in two group is 0.5g.The total time for therapy is 3 weeks in two groups. Assessment indicators：vagine PH, sIgA and IL-1βchanges, the degree of symptoms improving, onset time, edema-size of vaginal wall, vaginal discharge, and relapses and retreatment effect. ;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00984399 -
Serum Estradiol Levels In Postmenopausal Women With Breast Cancer Receiving Adjuvant Aromatase Inhibitors and Vaginal Estrogen
|
N/A | |
| Completed |
NCT04079218 -
Accelerated Genital Tract Aging in HIV: Estradiol Clinical Trial
|
Phase 4 | |
| Recruiting |
NCT05953090 -
VALOR: Vaginal Atrophy & Long-term Observation of Recovery
|
N/A | |
| Terminated |
NCT00816556 -
A Trial to Evaluate the Efficacy of Low Dose Vaginal Estrogens in the Treatment of Atrophic Vaginitis
|
Phase 3 | |
| Completed |
NCT00167921 -
Study Comparing Premarin® Vaginal Cream Versus Premarin® Oral Tablets in Atrophic Vaginitis
|
Phase 1 | |
| Completed |
NCT04327947 -
Evaluation of Gynecological Acceptability of 3 Health Care Products
|
N/A | |
| Recruiting |
NCT05118685 -
Estrogen and Platelet Rich Plasma in Treatment of Atrophic Vaginitis
|
Phase 1 | |
| Completed |
NCT03294538 -
Study to Evaluate Equivalence of Estradiol Vaginal Cream 0.01% to Estrace® Cream 0.01% in Atrophic Vaginitis
|
Phase 3 | |
| Completed |
NCT05058313 -
Evaluation of the Safety and Performance of the MILTA GYNECO Vaginal Probe in Postmenopausal Women With Vaginal Atrophy
|
N/A | |
| Completed |
NCT02995694 -
A Study Comparing Estradiol Vaginal Cream to Estrace® Cream in Females With Atrophic Vaginitis
|
Phase 3 | |
| Completed |
NCT02691936 -
Comparison of Vaginal Laser Therapy to Vaginal Estrogen Therapy
|
N/A | |
| Recruiting |
NCT06305494 -
Genitourinary Syndrome of Menopause in Thai Gynecologic Cancer Survivors
|
||
| Completed |
NCT02195986 -
A Comparison of Estradiol Vaginal Cream to Estrace® Cream in 350 Postmenopausal Females With Atrophic Vaginitis
|
Phase 3 | |
| Recruiting |
NCT03981458 -
Hyaluronate for the Treatment and Prevention of Recurrent Urinary Tract Infection in Women Suffering Atrophic Vaginitis
|
N/A | |
| Completed |
NCT05396261 -
a Flexible Wound Dressing for the Management of Genital Skin Conditions
|
N/A | |
| Completed |
NCT02869165 -
Vaginal and Urinary Microbiome Trial
|
Phase 4 | |
| Completed |
NCT02029053 -
Preliminary Study of a Vaginal Lubrication Ring to Treat the Symptoms of Vaginal Dryness
|
Phase 0 | |
| Not yet recruiting |
NCT06176820 -
Vaginal Hyaluronic Acid, Arginine and Liposome Gel Versus Vaginal Lubricant in Postmenopausal Women With Genitourinary Syndrome of Menopause
|
Phase 2/Phase 3 | |
| Withdrawn |
NCT02460302 -
Vaginal Progesterone Versus Placebo for the Treatment of Vaginal Atrophy
|
Phase 2 | |
| Completed |
NCT02313545 -
Phase I-B Study to Evaluate the Safety, Tolerability and Efficacy of IZN-6NVS for the Treatment of AV and DIV
|
Phase 1/Phase 2 |